2022
Vesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomy
Harold JA, Casilla-Lennon M, Kenney PA, Ratner ES. Vesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomy. BMJ Case Reports 2022, 15: e245015. PMID: 35383096, PMCID: PMC8984011, DOI: 10.1136/bcr-2021-245015.Peer-Reviewed Original ResearchConceptsClear cell adenocarcinomaPartial cystectomyCell adenocarcinomaMüllerian originPAX-8 stainingExtensive endometriosisAdjuvant therapyFinal pathologyTotal hysterectomyTransurethral resectionBladder massResidual tumorCystectomyAdenocarcinomaHysterectomyEndometriosisResectionTherapyTumorsPathologyWomen
2021
Cachexia and bladder cancer: clinical impact and management
Lokeshwar SD, Press BH, Nie J, Klaassen Z, Kenney PA, Leapman MS. Cachexia and bladder cancer: clinical impact and management. Current Opinion In Supportive And Palliative Care 2021, 15: 260-265. PMID: 34698663, DOI: 10.1097/spc.0000000000000580.Peer-Reviewed Original ResearchMeSH KeywordsCachexiaCystectomyHumansPalliative CareSarcopeniaTumor MicroenvironmentUrinary Bladder NeoplasmsConceptsRadical cystectomyBladder cancerPharmacological agentsManagement of cachexiaNovel pharmaceutical agentsPostoperative complicationsWorse survivalMultidisciplinary managementClinical outcomesHypercatabolic statePalliative carePoor outcomeClinical trialsNutritional supplementationBCa patientsClinical impactPhysical therapyCachexiaRadiation therapyHuman studiesPatientsTherapeutic outcomesNutritional deficienciesNutritional supplementsTumor microenvironmentIncidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries
Nguyen KA, Le DQ, Bui YT, Advani SD, Renzulli J, Kenney PA, Leapman MS. Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries. World Journal Of Urology 2021, 39: 2995-3003. PMID: 33471163, PMCID: PMC7816064, DOI: 10.1007/s00345-020-03551-y.Peer-Reviewed Original ResearchConceptsNational Surgical Quality Improvement ProgramLength of stayRadical cystectomyUrinary diversionUrological surgeryPostoperative CDIHospital readmissionSurgery typeRisk factorsMultivariable logistic regression analysisSurgical Quality Improvement ProgramPreoperative renal failureRisk of CDISubset of patientsMultivariable logistic regressionIncidence of CDIClostridioides difficile infectionPublic health burdenLogistic regression analysisQuality Improvement ProgramRenal failureSecondary outcomesBlood lossBlood transfusionClinical outcomes
2019
Outcomes for urologic oncology procedures: are there differences between academic and community hospitals?
Syed JS, Abello A, Nguyen J, Lee AJH, Desloges JJ, Leapman MS, Kenney PA. Outcomes for urologic oncology procedures: are there differences between academic and community hospitals? World Journal Of Urology 2019, 38: 1187-1193. PMID: 31420696, DOI: 10.1007/s00345-019-02902-8.Peer-Reviewed Original ResearchConceptsLength of stayCommunity hospitalAcademic hospitalReadmission ratesRadical cystectomyHospital-based outcomesDirect costsMean direct costUrologic oncology proceduresStudent's t-testCase mix indexIndex admissionVizient databaseRadical nephroureterectomyPartial cystectomySurgical treatmentUrologic malignanciesOncologic proceduresPartial nephrectomyCystectomyOncology proceduresAcademic centersHospitalProstatectomyStay